<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04612660</url>
  </required_header>
  <id_info>
    <org_study_id>HPV Self-sampling</org_study_id>
    <nct_id>NCT04612660</nct_id>
  </id_info>
  <brief_title>HPV Self-test to Increase Cervical Cancer Screening in Asian Women</brief_title>
  <official_title>Human Papillomavirus (HPV) and Cervical Cancer Intervention to Increase Cervical Cancer Screening for Underserved Asian Women</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was to pilot test the feability of using HPV self-sampling testing to increase&#xD;
      cervical cancer screening among under-served Asian women through engaging community-based&#xD;
      organizations in the greater Philadelphia and New York City area, addressing a significant&#xD;
      global cancer burden, the preventable infection-related cervical cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2014</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the change in the rate of cervical cancer screening</measure>
    <time_frame>baseline, and 6-month follow up</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">293</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>Specific Education and Dynamic Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Motivational group education specifically focused on cervical cancer prevention;&#xD;
Dynamic group interaction and role play discussion sessions on the benefits of Self-Sample collection HPV testing and procedures;&#xD;
Engaging community bilingual physicians in cervical cancer screening and referral;&#xD;
Patient navigation assistance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General Health Education</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparison group participants received general health education focusing on healthy lifestyle, and prevention of disease through routine health examinations.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Education on cervical cancer prevetnion</intervention_name>
    <description>Motivational group education by trained bilingual community health educators (CHEs) on cervical cancer prevention</description>
    <arm_group_label>Specific Education and Dynamic Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dynamic group interaction</intervention_name>
    <description>Dynamic group interaction and role play discussion sessions on the benefits of Self-Sample collection HPV testing and procedures;</description>
    <arm_group_label>Specific Education and Dynamic Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Physician engagement</intervention_name>
    <description>Engaging community bilingual physicians in cervical cancer screening and referral;</description>
    <arm_group_label>Specific Education and Dynamic Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Patient Navigation</intervention_name>
    <description>Patient navigation assistance will be provided to participants who tested HPV positive for further diagnostic testing and treatment.</description>
    <arm_group_label>Specific Education and Dynamic Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>General Health Education</intervention_name>
    <description>general health education focusing on healthy lifestyle, and prevention of disease through routine health examinations.</description>
    <arm_group_label>General Health Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. gender: female&#xD;
&#xD;
          2. age: 30-55&#xD;
&#xD;
          3. no current diagnosis of cervical cancer, and&#xD;
&#xD;
          4. have not participated in cervical cancer screening within the past 3 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grace Ma, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Center for Asian Health, Lewis Katz School of Medicine, Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>October 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2020</study_first_posted>
  <last_update_submitted>October 28, 2020</last_update_submitted>
  <last_update_submitted_qc>October 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

